XML 47 R73.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Segment Reporting - Revenues (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Nov. 30, 2019
Dec. 01, 2018
Nov. 30, 2019
Dec. 01, 2018
Segment Reporting        
Revenues $ 5,462,298 $ 5,450,060 $ 16,201,151 $ 16,259,912
Gross Profit 1,188,975 1,182,088 3,460,137 3,511,988
Adjusted EBITDA 158,090 142,791 402,627 429,364
Additions to property and equipment and intangible assets 62,802 57,707 162,570 170,791
Retail Pharmacy        
Segment Reporting        
Revenues 3,909,946   11,622,858  
Operating segments | Retail Pharmacy        
Segment Reporting        
Revenues 3,909,946 3,976,719 11,622,858 11,785,996
Gross Profit 1,070,852 1,079,584 3,133,791 3,200,678
Adjusted EBITDA 108,579 101,225 285,260 308,972
Additions to property and equipment and intangible assets 58,546 54,337 146,118 159,706
Operating segments | Pharmacy Services        
Segment Reporting        
Revenues 1,613,109 1,525,837 4,758,470 4,630,410
Gross Profit 118,123 102,504 326,346 311,310
Adjusted EBITDA 49,511 41,566 117,367 120,392
Additions to property and equipment and intangible assets 4,256 3,370 16,452 11,085
Intersegment elimination        
Segment Reporting        
Revenues $ (60,757) $ (52,496) $ (180,177) $ (156,494)